Will Carroll, Pharm.D., of Sutter Health says future pharmacy leaders need business, finance and AI skills, and health systems need real sponsorship.
News|Articles|January 14, 2025
- MHE January 2025
- Volume 35
- Issue 1
Out-of-Pocket Limits Increase Utilization | Predictions for 2025
Author(s)Jerilyn Arneson, Pharm. D
Jerilyn Arneson, Pharm. D, co-founder and officer of the National Association of Medication Access & Patient Advocacy, gives her 2025 prediction.
Advertisement
The lower out-of-pocket maximum in Medicare Part D plans might encourage some patients to use more healthcare services, including prescription drugs, that they previously couldn’t afford and, thus, never had filled. This increased utilization could lead to more people hitting the $2,000 limit and increasing the demand for foundation assistance.
Articles in this issue
almost 2 years ago
Lab Power | Predictions for 2025almost 2 years ago
Here we are Now, Enable us | Predictions for 2025almost 2 years ago
Telehealth, the Fully Hybridized Version | Prediction for 2025almost 2 years ago
Cybersecurity on Health Plan Radar | Predictions for 2025almost 2 years ago
Simulacra of Data as an Answer | Predictions for 2025almost 2 years ago
AI Soups up Payer Operations | Predictions for 2025almost 2 years ago
Digital Lifeline | Predictions for 2025Advertisement
Related to this article
Will Carroll, Pharm.D., of Sutter Health says pharmacy is often handed strategy to execute instead of shaping it, and must show value in C-suite terms.
Ty Gluckman, M.D., says undertesting and undertreatment are the biggest gaps in lipid care and calls on leaders to invest in cardiovascular prevention.
Ty Gluckman, M.D., says the 2026 dyslipidemia guideline brings back risk-based LDL goals, and clinical inertia, not access, is now the biggest barrier.
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacists improve outcomes but often can’t bill for it, making billing parity key to growing services.
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse.
Robotic lobectomies grew from 49% to 70% of cases from 2020 to 2024 as access and training expanded, says Staci Beamer, M.D., of HonorHealth.
AI analyzes single-lead ECGs from sleep studies to predict atrial fibrillation, heart failure, and mortality risk, enabling scalable cardiovascular disease screening.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Heart data in sleep study predicts atrial fibrillation, heart failure years in advance
2
Will Carroll, Pharm.D., on developing future pharmacy executives | HSES 2026
3
Will Carroll, Pharm.D., on moving pharmacy upstream in strategy | HSES 2026
4
Ty Gluckman, M.D., on closing the gaps in lipid testing and treatment | HSES 2026
5